The microbiome—a vast ecosystem of microbes within our bodies—is emerging as a foundational platform for health, influencing everything from immunity and digestion to mental health and drug response. Despite growing scientific evidence, the healthcare industry often treats it as a niche trend, limiting its potential. The article argues for a paradigm shift: to stop viewing the microbiome as a wellness product and start integrating it into diagnostics, chronic care, and personalized medicine. The future of healthcare, it suggests, may depend not on external innovation, but on unlocking the power of the microscopic world within us.
Trending
- Cancer risk comparable across advanced IBD therapies in claims analysis (GI & Hepatology News)
- Independent practice on the road to extinction: Why the next generation won’t own the stethoscope, let alone the building (Medical Economics)
- Fecal Burden on CT Weakly Correlates with Bowel Function in Adults and is Poorly Associated with Clinical Symptoms (Digestive Diseases and Sciences)
- Cook Medical issues medical device correction for Hemospray Endoscopic Hemostat (AGA)
- Medicare physician pay reform 2027: Patients First Act and 4 other bills explained (Physicians Practice)
- FDA Advisory Committee Votes In Favor of Approval of GRAIL’s Galleri® Multi-Cancer Early Detection Test (PR Newswire)
- Batteries that safely break down in the GI tract could improve ingestible devices (Medical Xpress)
- Management of Obesity: Review of Adjunctive Therapies and Clinical Management Pearls (Gastroenterology)
